Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ingrid Caras"'
Autor:
Weihua Song, Daniel E. H. Afar, Peter Burger, Yu-Tzu Tai, Hervé Avet-Loiseau, Wanling Xie, Paul G. Richardson, Claire Mathiot, Audie G. Rice, Anne van Abbema, Xian Feng Li, Kenneth C. Anderson, Lynne Jesaitis, Edie Weller, Ingrid Caras, Alfred Ian Lee, Klaus Podar, Teru Hideshima, Nikhil C. Munshi, Myles B.C. Dillon, Merav Leiba, Debbie A. Law
Publikováno v:
Blood. 112:1329-1337
Currently, no approved monoclonal antibody (mAb) therapies exist for human multiple myeloma (MM). Here we characterized cell surface CS1 as a novel MM antigen and further investigated the potential therapeutic utility of HuLuc63, a humanized anti-CS1
Publikováno v:
Journal of Immunological Methods. 315:80-87
Confirmatory assays for immunogenicity testing typically involve testing a sample in the presence or absence of excess drug. A decrease in assay signal in the presence of drug is taken to indicate the presence of anti-drug antibodies (ADAb) and the s
Autor:
Steven D. Shapiro, Richard Murray, Harold A. Chapman, Stephen J. Weiss, Sergey Filippov, Lynn M. Matrisian, Ingrid Caras
Publikováno v:
The Journal of Experimental Medicine
The Journal of experimental medicine, vol 198, iss 6
The Journal of experimental medicine, vol 198, iss 6
Human macrophages found in juxtaposition to fragmented elastin in vivo express the elastolytic matrix metalloproteinases (MMPs) progelatinase B, prometalloelastase, and promatrilysin. Though MMPs can degrade a range of extracellular matrix components
Publikováno v:
Cytotechnology. 35:189-196
Genomics-based approaches are increasingly being used to identify disease-associated genes that represent potential new drug targets. As a first step in the validation of genes of unknown function, we describe a method for rapidly determining the sub
Autor:
Antonello Punturieri, Richard Murray, Edward D. Allen, Stephen J. Weiss, Ingrid Caras, Vivek Y. Reddy, Sergey Filippov
Publikováno v:
The Journal of Experimental Medicine
Human macrophages mediate the dissolution of elastic lamina by mobilizing tissue-destructive cysteine proteinases. While macrophage-mediated elastin degradation has been linked to the expression of cathepsins L and S, these cells also express catheps
Autor:
Vanitha, Ramakrishnan, Vinay, Bhaskar, Debbie A, Law, Melanie H L, Wong, Robert B, DuBridge, Danna, Breinberg, Christopher, O'Hara, David B, Powers, Gao, Liu, Jennifer, Grove, Peter, Hevezi, Kellie M, Cass, Susan, Watson, Ferdinand, Evangelista, Rick A, Powers, Barbara, Finck, Margaret, Wills, Ingrid, Caras, Yuni, Fang, Donald, McDonald, Dale, Johnson, Richard, Murray, Ursula, Jeffry
Publikováno v:
Journal of experimental therapeuticsoncology. 5(4)
Integrin alpha5beta1, the principal fibronectin receptor, is an important survival factor, playing a key role in angiogenesis. Angiogenesis is critical for tumor growth, and anti-angiogenic therapies have met clinical success. To validate the therape
Autor:
Gordon F. O'Neill, Susan M. Henshall, Kurt C. Gish, David Golovsky, David I. Quinn, Melanie Wong, James G. Kench, Phillip Brenner, Jennifer Turner, Warick Delprado, John J. Grygiel, Raji Kooner, David H. Mack, Daniel E. H. Afar, Robert L. Sutherland, Phillip D. Stricker, Ingrid Caras, Lisa G. Horvath, C-Soon Lee, Ursula Jeffry, Vanitha Ramakrishnan, K. Rasiah
Publikováno v:
Oncogene. 22(38)
We have utilized oligonucleotide microarrays to identify novel genes of potential clinical and biological importance in prostate cancer. RNA from 74 prostate cancers and 164 normal body samples representing 40 different tissues were analysed using a
Publikováno v:
Cerebral cortex (New York, N.Y. : 1991). 9(6)
The development of axonal connections between thalamic nuclei and their cortical target areas occurs in a highly specific manner. To explore the mechanisms of thalamocortical axon pathfinding, we investigated the expression of several members of the
Autor:
William Bensinger, Ann Mohrbacher, Anil Singhal, Nikhil C. Munshi, Jeffrey A. Zonder, Seema Singhal, Mohamad A. Hussein, Frits van Rhee, Ingrid Caras
Publikováno v:
Blood. 112:2773-2773
Elotuzumab is a humanized monoclonal antibody directed against CS1, a cell surface glycoprotein, which is highly and uniformly expressed in multiple myeloma. Elotuzumab has demonstrated significant anti-tumor activity in pre-clinical mouse models of
Autor:
Jordan Hiller, Ingrid Caras, Zhanna Kobalava, Markus Meyer, Wolf-Georg Forssmann, Veselin Mitrovic, Petar M. Seferović, Jadine Moy, Hartmut Lüss
Publikováno v:
Journal of Cardiac Failure. 13:S136